Product Overview
As opposed to a traditional eTMF, myClin updates all your key study documents and interactions instantaneously. Use your eTMF as an efficient study management tool instead of a simple repository. Build a perfectly organized, inspection-ready eTMF. Optimize document creation by allowing the author to distribute and correctly code items as they go along – cutting out later reconciliation tasks. Documents can appear on one or both the TMF and an ISF simultaneously, as controlled by the author.
All stakeholders can access the latest study materials when they need them with automatic proof they have accessed the correct versions.
Deployment
- Web based
- Cloud Hosted
Pricing
- Subscription
- License Fee
More Information
Document control and collaboration
myClin acts as a collaborative, living eTMF solution. Upload and share study documents in seconds on your central and secure myClin channels. Easy access allows for accelerated delivery of critical study updates and training.
About the company
myClin is the leading Software as a Service (SaaS) platform for essential Clinical Trial Compliance and Oversight. It allows for secure document exchange between sites, sponsors and CROs, automatically tracked study communications, centralized and accelerated study training, and unique Compliance Scoring insights.
The myClin Compliance Score gives all study stakeholders the ability to identify and measure hidden study compliance gaps. You can track and improve the readership of essential study documents and the delivery of critical study updates and training. It provides clear and objective metrics for all stakeholders to stay inspection-ready and ensure continuous and contemporaneous oversight.
Since 2008 our mission has been to leverage technology to enhance oversight, compliance, engagement and collaboration in clinical trials. The team of clinical research veterans that created myClin brought deep experience delivering clinical operations services and building feature-rich eClinical systems. Since then, myClin has been used across all phases of research, in global bio-pharmaceutical and device studies with thousands of clinical users.